Law Project for Psychiatric Rights
The FDA (Food and Drug Administration) issued a statement recently, advising health care professionals that it has updated product labels on Anti-psychotic drugs, warning of pregnancy dangers to newborns including EPS and withdrawal symptoms.
Anti-psychotic drugs included in the new labeling process and contra-indicated for use in pregnancy include: Haldol, FazaClo, Fanapt, Clozaril, Risperdal, Zyprexa, Seroquel, Abilify, Geodon, Invega, Loxitane, Moban, Navane, Orap, Saphris, Stelazine, Thorazine and Symbyax.
No comments:
Post a Comment